Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

R. Peffault De Latour; C. Peters; B. Gibson; B. Strahm; A. Lankester; C. D. De Heredia; D. Longoni; F. Fioredda; F. Locatelli; I. Yaniv; J. Wachowiak; J. Donadieu; A. Lawitschka; M. Bierings; M. Wlodarski; S. Corbacioglu; S. Bonanomi; S. Samarasinghe; T. Leblanc; C. Dufour; J. H. Dalle

doi:10.1038/bmt.2015.117

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

R. Peffault De Latour, C. Peters, B. Gibson, B. Strahm, A. Lankester, C. D. De Heredia, D. Longoni, F. Fioredda, F. Locatelli, I. Yaniv, J. Wachowiak, J. Donadieu, A. Lawitschka, M. Bierings, M. Wlodarski, S. Corbacioglu, S. Bonanomi, S. Samarasinghe, T. Leblanc, C. DufourJ. H. Dalle

Research output: Contribution to journal › Article

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential to cure patients with an inherited bone marrow failure syndrome (IBMFS). However, the procedure involves the risk of treatment-related mortality and may be associated with significant early and late morbidity. For these reasons, the benefits should be carefully weighed against the risks. IBMFS are rare, whereas case reports and small series in the literature illustrate highly heterogeneous practices in terms of indications for HSCT, timing, stem cell source and conditioning regimens. A consensus meeting was therefore held in Vienna in September 2012 on behalf of the European Group for Blood and Marrow Transplantation to discuss HSCT in the setting of IBMFS. This report summarizes the recommendations from this expert panel, including indications for HSCT, timing, stem cell source and conditioning regimen.

Original language	English
Pages (from-to)	1168-1172
Number of pages	5
Journal	Bone Marrow Transplantation
Volume	50
Issue number	9
DOIs	https://doi.org/10.1038/bmt.2015.117
Publication status	Published - Sep 4 2015

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/bmt.2015.117

Fingerprint Dive into the research topics of 'Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes'. Together they form a unique fingerprint.

Cite this

Peffault De Latour, R., Peters, C., Gibson, B., Strahm, B., Lankester, A., De Heredia, C. D., Longoni, D., Fioredda, F., Locatelli, F., Yaniv, I., Wachowiak, J., Donadieu, J., Lawitschka, A., Bierings, M., Wlodarski, M., Corbacioglu, S., Bonanomi, S., Samarasinghe, S., Leblanc, T., ... Dalle, J. H. (2015). Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes. Bone Marrow Transplantation, 50(9), 1168-1172. https://doi.org/10.1038/bmt.2015.117

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes. / Peffault De Latour, R.; Peters, C.; Gibson, B.; Strahm, B.; Lankester, A.; De Heredia, C. D.; Longoni, D.; Fioredda, F.; Locatelli, F.; Yaniv, I.; Wachowiak, J.; Donadieu, J.; Lawitschka, A.; Bierings, M.; Wlodarski, M.; Corbacioglu, S.; Bonanomi, S.; Samarasinghe, S.; Leblanc, T.; Dufour, C.; Dalle, J. H.

In: Bone Marrow Transplantation, Vol. 50, No. 9, 04.09.2015, p. 1168-1172.

Research output: Contribution to journal › Article

Peffault De Latour, R, Peters, C, Gibson, B, Strahm, B, Lankester, A, De Heredia, CD, Longoni, D, Fioredda, F , Locatelli, F, Yaniv, I, Wachowiak, J, Donadieu, J, Lawitschka, A, Bierings, M, Wlodarski, M, Corbacioglu, S, Bonanomi, S, Samarasinghe, S, Leblanc, T, Dufour, C & Dalle, JH 2015, 'Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes', Bone Marrow Transplantation, vol. 50, no. 9, pp. 1168-1172. https://doi.org/10.1038/bmt.2015.117

Peffault De Latour, R. ; Peters, C. ; Gibson, B. ; Strahm, B. ; Lankester, A. ; De Heredia, C. D. ; Longoni, D. ; Fioredda, F. ; Locatelli, F. ; Yaniv, I. ; Wachowiak, J. ; Donadieu, J. ; Lawitschka, A. ; Bierings, M. ; Wlodarski, M. ; Corbacioglu, S. ; Bonanomi, S. ; Samarasinghe, S. ; Leblanc, T. ; Dufour, C. ; Dalle, J. H. / Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes. In: Bone Marrow Transplantation. 2015 ; Vol. 50, No. 9. pp. 1168-1172.

@article{f84ab1080f044eb19911398d4351c8bd,

title = "Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes",

abstract = "Allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential to cure patients with an inherited bone marrow failure syndrome (IBMFS). However, the procedure involves the risk of treatment-related mortality and may be associated with significant early and late morbidity. For these reasons, the benefits should be carefully weighed against the risks. IBMFS are rare, whereas case reports and small series in the literature illustrate highly heterogeneous practices in terms of indications for HSCT, timing, stem cell source and conditioning regimens. A consensus meeting was therefore held in Vienna in September 2012 on behalf of the European Group for Blood and Marrow Transplantation to discuss HSCT in the setting of IBMFS. This report summarizes the recommendations from this expert panel, including indications for HSCT, timing, stem cell source and conditioning regimen.",

author = "{Peffault De Latour}, R. and C. Peters and B. Gibson and B. Strahm and A. Lankester and {De Heredia}, {C. D.} and D. Longoni and F. Fioredda and F. Locatelli and I. Yaniv and J. Wachowiak and J. Donadieu and A. Lawitschka and M. Bierings and M. Wlodarski and S. Corbacioglu and S. Bonanomi and S. Samarasinghe and T. Leblanc and C. Dufour and Dalle, {J. H.}",

year = "2015",

month = sep,

day = "4",

doi = "10.1038/bmt.2015.117",

language = "English",

volume = "50",

pages = "1168--1172",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

AU - Peffault De Latour, R.

AU - Peters, C.

AU - Gibson, B.

AU - Strahm, B.

AU - Lankester, A.

AU - De Heredia, C. D.

AU - Longoni, D.

AU - Fioredda, F.

AU - Locatelli, F.

AU - Yaniv, I.

AU - Wachowiak, J.

AU - Donadieu, J.

AU - Lawitschka, A.

AU - Bierings, M.

AU - Wlodarski, M.

AU - Corbacioglu, S.

AU - Bonanomi, S.

AU - Samarasinghe, S.

AU - Leblanc, T.

AU - Dufour, C.

AU - Dalle, J. H.

PY - 2015/9/4

Y1 - 2015/9/4

N2 - Allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential to cure patients with an inherited bone marrow failure syndrome (IBMFS). However, the procedure involves the risk of treatment-related mortality and may be associated with significant early and late morbidity. For these reasons, the benefits should be carefully weighed against the risks. IBMFS are rare, whereas case reports and small series in the literature illustrate highly heterogeneous practices in terms of indications for HSCT, timing, stem cell source and conditioning regimens. A consensus meeting was therefore held in Vienna in September 2012 on behalf of the European Group for Blood and Marrow Transplantation to discuss HSCT in the setting of IBMFS. This report summarizes the recommendations from this expert panel, including indications for HSCT, timing, stem cell source and conditioning regimen.

AB - Allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential to cure patients with an inherited bone marrow failure syndrome (IBMFS). However, the procedure involves the risk of treatment-related mortality and may be associated with significant early and late morbidity. For these reasons, the benefits should be carefully weighed against the risks. IBMFS are rare, whereas case reports and small series in the literature illustrate highly heterogeneous practices in terms of indications for HSCT, timing, stem cell source and conditioning regimens. A consensus meeting was therefore held in Vienna in September 2012 on behalf of the European Group for Blood and Marrow Transplantation to discuss HSCT in the setting of IBMFS. This report summarizes the recommendations from this expert panel, including indications for HSCT, timing, stem cell source and conditioning regimen.

UR - http://www.scopus.com/inward/record.url?scp=84940888826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940888826&partnerID=8YFLogxK

U2 - 10.1038/bmt.2015.117

DO - 10.1038/bmt.2015.117

M3 - Article

C2 - 26052913

AN - SCOPUS:84940888826

VL - 50

SP - 1168

EP - 1172

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 9

ER -